Myeloma
The Royal Marsden offers a range of myeloma treatment and care services for patients at its hospitals in Chelsea, London, and Sutton, Surrey.
Myeloma services at The Royal Marsden
- Diagnosis, tests and investigations: primary assessment and diagnosis in partnership with other hospitals
- Cancer genetics
- Chemotherapy
- Radiotherapy
- Stem cell transplant, total body irradiation
- Critical care
- Rehabilitation, including a pre-transplant programme
- Palliative and supportive care
Services are provided through a specialised inpatient unit for the delivery of more intensive chemotherapy and a newly refurbished outpatient area
Primary assessment and diagnosis
- Full blood count
- Biochemistry
- Immunoglobulins testing
- Paraprotein testing
- Serum free light chain measurement
- Bone marrow estimation
- Skeletal surveys
- MRI
- PET CT
- Bone marrow genetics
- FISH (fluorescence in situ hybridisation)
- Cytogenetics
- Novel prognostic markers
Treatment
- Stem cell transplants (autologous and allogeneic donor transplants)
- Chemotherapy using drugs such as Thalidomide, Velcade and Revlimid
- Intensive strategies for aggressive disease
- Access to novel drugs and clinical trials
Patient care and support
- Clinical nurse specialist in myeloma
- Specialist transplant nurses
- Pain control
- Orthopaedic and renal links